Venatorx Pharmaceuticals

Venatorx Pharmaceuticals Strikes Deal with Menarini Group for Global Rights to Cefepime-Taniborbactam

MALVERN, PA — Venatorx Pharmaceuticals recently granted exclusive commercial rights to Italy’s Menarini Group for its novel antibiotic, cefepime-taniborbactam. The agreement extends to 96 countries in Europe, Latin America, Middle …

Venatorx Pharmaceuticals Strikes Deal with Menarini Group for Global Rights to Cefepime-Taniborbactam Read More
Business News

AmerCareRoyal Acquires Thermosource Tooling and Manufacturing, Expands Packaging Solutions Portfolio

EXTON, PA — AmerCareRoyal (ACR), a leading supplier of disposable foodservice supplies, has announced the recent acquisition of Thermosource Tooling and Manufacturing (TTM). The deal marks ACR’s ninth add-on acquisition …

AmerCareRoyal Acquires Thermosource Tooling and Manufacturing, Expands Packaging Solutions Portfolio Read More



Aclaris Therapeutics

Aclaris Therapeutics Announces Promising Phase 2b Results for ATI-1777, Boosting Investor Confidence

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has released promising top-line results from its Phase 2b study of ATI-1777, a topical “soft” JAK 1/3 inhibitor developed for treating mild …

Aclaris Therapeutics Announces Promising Phase 2b Results for ATI-1777, Boosting Investor Confidence Read More